Literature DB >> 15673513

Coexistence of multiple PCR-ribotype strains of Clostridium difficile in faecal samples limits epidemiological studies.

Renate J van den Berg1, Hadi Aa Ameen1, Takahiro Furusawa1, Eric Cj Claas1, Eric R van der Vorm1, Ed J Kuijper1.   

Abstract

Clostridium difficile is an important cause of antibiotic-associated diarrhoea. The simultaneous presence of different strains in individual faecal samples has not yet been established, but is important for epidemiological studies. Recurrences of Clostridium difficile-associated diarrhoea (CDAD) are observed in 15-20 % of patients and have been reported as relapses or reinfections with a new strain. In a period of 1 year, 28 faecal samples from 23 patients with a first episode of CDAD were collected at the Leiden University Medical Centre. In addition, 52 faecal samples from 23 patients, from three different hospitals, with one (n = 19), two (n = 2) or three (n = 2) recurrences were studied. PCR-ribotyping was applied as the standard typing method for the isolates. The toxinogenic and clindamycin-resistance profiles of the isolates was determined by PCR. Of 23 patients with a first episode of CDAD, two (8.7 %) harboured two different types, with no differences in toxinogenicity or clindamycin resistance, within one faecal sample. One of these 23 patients showed two types in three faecal samples from the same episode. Of the 23 patients with recurrences, six (26 %) showed a different strain type isolated in a recurrent episode. The number of cases of multiple C. difficile strains in faecal samples from patients with a first episode of CDAD did not differ significantly from the number of different strains present in recurrent episodes (chi-square test, P < or = 0.2). This observation limits the application of typing methods for studying the epidemiology of CDAD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15673513     DOI: 10.1099/jmm.0.45825-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  30 in total

1.  Use of modified PCR ribotyping for direct detection of Clostridium difficile ribotypes in stool samples.

Authors:  Sandra Janezic; Iztok Strumbelj; Maja Rupnik
Journal:  J Clin Microbiol       Date:  2011-06-01       Impact factor: 5.948

2.  Clostridium difficile mixed infection and reinfection.

Authors:  David W Eyre; A Sarah Walker; David Griffiths; Mark H Wilcox; David H Wyllie; Kate E Dingle; Derrick W Crook; Tim E A Peto
Journal:  J Clin Microbiol       Date:  2011-11-09       Impact factor: 5.948

3.  Frequent emergence of resistance in Clostridium difficile during treatment of C. difficile-associated diarrhea with fusidic acid.

Authors:  T Norén; M Wullt; Thomas Akerlund; E Bäck; I Odenholt; L G Burman
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

4.  Prospective multicenter evaluation of a new immunoassay and real-time PCR for rapid diagnosis of Clostridium difficile-associated diarrhea in hospitalized patients.

Authors:  Renate J van den Berg; Lesla S Bruijnesteijn van Coppenraet; Hendrik-Jan Gerritsen; Hubert P Endtz; Eric R van der Vorm; Ed J Kuijper
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

5.  Sustained clinical response as an endpoint in treatment trials of Clostridium difficile-associated diarrhea.

Authors:  Stuart Johnson; Dale N Gerding; Thomas J Louie; Nancy M Ruiz; Sherwood L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  2012-05-21       Impact factor: 5.191

6.  Impact of clinical awareness and diagnostic tests on the underdiagnosis of Clostridium difficile infection.

Authors:  L Alcalá; E Reigadas; M Marín; A Martín; P Catalán; E Bouza
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-04-24       Impact factor: 3.267

7.  Clostridium difficile ribotype 078 cultured from post-surgical non-healing wound in a patient carrying ribotype 014 in the intestinal tract.

Authors:  Otakar Nyc; Marcela Krutova; Jiri Kriz; Jana Matejkova; Eliska Bebrova; Veronika Hysperska; Ed J Kuijper
Journal:  Folia Microbiol (Praha)       Date:  2015-05-03       Impact factor: 2.099

8.  Presence of multiple Clostridium difficile strains at primary infection is associated with development of recurrent disease.

Authors:  Anna M Seekatz; Emily Wolfrum; Christopher M DeWald; Rosemary K B Putler; Kimberly C Vendrov; Krishna Rao; Vincent B Young
Journal:  Anaerobe       Date:  2018-05-31       Impact factor: 3.331

9.  Role of Coinfecting Strains in Recurrent Clostridium difficile Infection.

Authors:  Janet Sun; Tracy Mc Millen; N Esther Babady; Mini Kamboj
Journal:  Infect Control Hosp Epidemiol       Date:  2016-08-30       Impact factor: 3.254

10.  Comparison of a commercial real-time PCR assay for tcdB detection to a cell culture cytotoxicity assay and toxigenic culture for direct detection of toxin-producing Clostridium difficile in clinical samples.

Authors:  Paul D Stamper; Romina Alcabasa; Deborah Aird; Wisal Babiker; Jennifer Wehrlin; Ijeoma Ikpeama; Karen C Carroll
Journal:  J Clin Microbiol       Date:  2008-12-10       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.